Loading...
XSHG
600055
Market cap1.74bUSD
Aug 05, Last price  
17.63CNY
1D
0.40%
1Q
2.01%
Jan 2017
37.14%
Name

Beijing Wandong Medical Technology Co Ltd

Chart & Performance

D1W1MN
P/E
78.77
P/S
8.13
EPS
0.22
Div Yield, %
0.73%
Shrs. gr., 5y
5.58%
Rev. gr., 5y
9.18%
Revenues
1.52b
+23.26%
494,946,524514,811,927532,265,890603,596,283683,441,239602,754,359588,805,176690,346,218764,680,965739,874,867818,218,095813,400,702883,958,514954,529,650982,372,0191,131,904,7921,156,174,6861,121,203,5481,236,669,6301,524,354,161
Net income
157m
-16.54%
17,572,70229,541,24428,001,32228,366,29668,599,53241,945,18639,887,90332,257,02543,623,19825,692,56740,298,12471,543,783109,117,143153,333,141168,884,369220,667,405183,193,054175,369,143188,537,925157,350,997
CFO
218m
+4.82%
63,579,96248,545,425090,743,456144,175,3910065,747,96521,494,23634,324,6010102,736,486075,530,39594,784,204520,025,42489,723,684185,408,318208,218,000218,253,215
Dividend
May 17, 20240.13 CNY/sh

Profile

Beijing Wandong Medical Technology Co., Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic service. It offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, and mobile X-ray equipment. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. The company was founded in 1955 and is based in Beijing, China.
URL
https://www.wandong.com.cn/
IPO date
May 19, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,524,354
23.26%
1,236,670
10.30%
1,121,204
-3.02%
Cost of revenue
1,223,325
991,433
961,783
Unusual Expense (Income)
NOPBT
301,029
245,237
159,421
NOPBT Margin
19.75%
19.83%
14.22%
Operating Taxes
8,217
22,522
20,399
Tax Rate
2.73%
9.18%
12.80%
NOPAT
292,812
222,714
139,022
Net income
157,351
-16.54%
188,538
7.51%
175,369
-4.27%
Dividends
(84,367)
(70,306)
Dividend yield
0.71%
0.55%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
6,260
Long-term debt
28,652
22,374
31,329
Deferred revenue
19,590
26,637
Other long-term liabilities
23,833
38,801
17,207
Net debt
(3,557,727)
(3,779,646)
(3,531,706)
Cash flow
Cash from operating activities
218,253
208,218
185,408
CAPEX
(17,126)
Cash from investing activities
59,970
150,198
Cash from financing activities
(86,785)
2,024,965
FCF
307,865
220,334
103,941
Balance
Cash
3,586,379
3,440,843
3,341,791
Long term investments
2
361,177
227,503
Excess cash
3,510,161
3,740,186
3,513,234
Stockholders' equity
1,871,822
2,061,105
1,951,098
Invested Capital
3,063,916
2,809,507
2,791,271
ROIC
9.97%
7.95%
6.67%
ROCE
6.10%
5.03%
3.36%
EV
Common stock shares outstanding
703,061
698,289
649,515
Price
15.10
-11.59%
17.08
-12.59%
19.54
-17.93%
Market cap
10,616,222
-10.99%
11,926,770
-6.03%
12,691,530
-0.53%
EV
7,168,938
8,256,275
9,265,039
EBITDA
339,913
285,596
194,124
EV/EBITDA
21.09
28.91
47.73
Interest
1,647
1,698
1,466
Interest/NOPBT
0.55%
0.69%
0.92%